References
- Alam A, Voronovich Z, Carley JA. A review of therapeutic uses of mirtazapine in psychiatric and medical conditions. Prim Care Companion CNS Disord. 2013;15(5). doi:10.4088/PCC.13r01525.
- Laimer M, Kramer-Reinstadler K, Rauchenzauner M, Lechner-Schoner T, Strauss R, Engl J, Deisenhammer EA, Hinterhuber H, Patsch JR, Ebenbichler CF. Effect of mirtazapine treatment on body composition and metabolism. J Clin Psychiatry. 2006;67(3):421–4. doi:10.4088/jcp.v67n0313.
- Mirtazapine [package insert]. Oss, Netherlands. N.V.
- Tack J, Ly HG, Carbone F, Vanheel H, Vanuytsel T, Holvoet L, Boeckxstaens G, Caenepeel P, Arts J, Van Oudenhove L, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016;14(3):385–92.e4. doi:10.1016/j.cgh.2015.09.043.
- Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249–64. doi:10.1111/j.1527-3458.2001.tb00198.x.
- Berigan TR. Mirtazapine-associated withdrawal symptoms: a case report. Prim Care Companion J Clin Psychiatry. 2001;3(3):143. doi:10.4088/pcc.v03n0307a.
- Fava M. Weight gain and antidepressants. J Clin Psychiatry. 2000;61(Suppl 11):37–41.
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45. doi:10.1038/clpt.1981.154.
- Ikenouchi-Sugita A, Yoshimura R, Nakamura J. A case of discontinuation syndrome following the discontinuation of low-dose mirtazapine therapy in malignant lymphoma. Clin Neuropsychopharmacol Ther. 2011;2:30–1. doi:10.5234/cnpt.2.30.
- Benazzi F. Mirtazapine withdrawal symptoms. Can J Psychiatry. 1998;43(5):525.
- Fauchère PA. Recurrent, persisting panic attacks after sudden discontinuation of mirtazapine treatment: a case report. Int J Psychiatry Clin Pract. 2004;8(2):127–9. doi:10.1080/13651500410006134.
- Verma JK, Mohapatra S. Mirtazapine withdrawal-induced mania. J Pharmacol Pharmacother. 2015;6(4):214–5. doi:10.4103/0976-500X.171878.
- MacCall C, Callender J. Mirtazapine withdrawal causing hypomania. Br J Psychiatry. 1999;175:390. doi:10.1192/bjp.175.4.390a.
- Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord. 1998;51(3):267–85. doi:10.1016/s0165-0327(98)00224-9.